VolitionRx Limited (AMEX:VNRX) Q3 2022 Earnings Call Transcript

VolitionRx Limited (AMEX:VNRX) Q3 2022 Earnings Call Transcript November 15, 2022

VolitionRx Limited beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.15.

Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited’s Third Quarter 2022 Earnings Conference Call. This conference is being recorded today, November 15, 2022. I’d now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations....